Myocardial infarction is a key component of the burden of cardiovascular disease. The assessment of the incidence and case fatality of myocardial infarction are important determinants of the decline in coronary disease mortality. The change in biomarkers used to diagnose myocardial infarction raises several methodologic, clinical, and public health challenges, which are discussed herein.
|Original language||English (US)|
|Number of pages||16|
|Journal||Medical Clinics of North America|
|State||Published - Jul 2007|
ASJC Scopus subject areas